Persist AI

Private Company

Develop extended-release injectable drug formulations 30-50% faster

Pharmaceutical Manufacturing
West Sacramento, California
2-10 employees
Founded 2022

About Persist AI

Persist AI is revolutionizing pharmaceutical development with an AI-powered platform and robotic cloud labs that accelerate drug formulation discovery from years to months. Serving pharmaceutical and biotech companies, its technology predicts optimal formulations and automates high-throughput experimentation. The company offers a full suite of services from discovery and analytical support to cGMP manufacturing.

Company Classification

Customer Types
B2B
Business Models
ProductsServices
Product & Service Types
AI drug formulation platformRobotic cloud lab servicesPharmaceutical development & manufacturing services

Funding

Total Funding

$4.50M

No. of Funding Rounds

2

Customers

CustomerSuccess StorySource
Nivagen
Collaborated with Persist AI to develop a next‑generation AI‑driven manufacturing process for long‑acting injectable drugs.
OSD Pharmaceuticals Solutions Inc.
Utilized Persist AI's platform for high throughput formulation screening and AI-driven predictions to develop pharmaceutical solutions.

Sign up to Ethos to access the full customer list, plus detailed competitor and product analysis.

Sign up to Ethos